An article discusses the performance of Verona Pharma plc (NASDAQ:VRNA) compared to other soaring stocks on Tuesday. VRNA saw an 8-day rally due to impressive earnings, narrowing net loss and high revenues from COPD treatment. CEO is optimistic about future prospects.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing